Wild-type ras has GTPase activity, and this activity is accelerated substantially by GTPase-activating proteins (GAPs). Oncogenic ras species have an abnormally low intrinsic GTPase activity, and this activity is insensitive to GAPs. We confirmed that the anti-ras monoclonal antibody Y13-238 inhibit
Inhibition of Ras oncogenic activity by Ras protooncogenes
✍ Scribed by Roberto Diaz; Jeffrey Lue; Jeremy Mathews; Andrew Yoon; Daniel Ahn; Antonio Garcia-España; Peter Leonardi; Marcelo P. Vargas; Angel Pellicer
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- French
- Weight
- 376 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Point mutations in ras genes have been found in a large number and wide variety of human tumors. These oncogenic Ras mutants are locked in an active GTP‐bound state that leads to a constitutive and deregulated activation of Ras function. The dogma that ras oncogenes are dominant, whereby the mutation of a single allele in a cell will predispose the host cell to transformation regardless of the presence of the normal allele, is being challenged. We have seen that increasing amounts of Ras protooncogenes are able to inhibit the activity of the N‐Ras oncogene in the activation of Elk in NIH 3T3 cells and in the formation of foci. We have been able to determine that the inhibitory effect is by competition between Ras protooncogenes and the N‐Ras oncogene that occurs first at the effector level at the membranes, then at the processing level and lastly at the effector level in the cytosol. In addition, coexpression of the N‐Ras protooncogene in thymic lymphomas induced by the N‐Ras oncogene is associated with increased levels of p107, p130 and cyclin A and decreased levels of Rb. In the present report, we have shown that the N‐Ras oncogene is not truly dominant over Ras protooncogenes and their competing activities might be depending on cellular context.
📜 SIMILAR VOLUMES
The Harvey-ras gene encodes small guanine nucleotide binding proteins, mutant forms of which are associated with a number of human malignancies. Based on studies with truncated forms of the protein it is known that correct post-translational processing of Ras is essential for cytoplasmic membrane lo
A lipophilic farnesyl moiety attached to the carboxyl terminal cysteine of ras proteins structurally supports their membrane anchorage, required for ras-dependent growth-factor signaling and for transforming activity of ras oncoproteins. It has been shown that inhibition of ras farnesylation can blo
The antitumor natural product RA-VII has been evaluated as an inhibitor of protein synthesis in vitro. Complete inhibition of protein synthesis in rabbit reticulocyte lysates is observed with \(5 \mu \mathrm{m}\) RA-VII. Mechanistic studies using purified elongation factors and ribosomes identify RA
## Background: In hong kong, lung carcinomas contribute to the majority of cancer deaths among chinese. point mutational activation of ras oncogenes has been observed in several populations. the incidence of these mutations in hong kong lung carcinomas was investigated. ## Methods: Lung resection